Seeking Alpha

Vitamin Shoppe's (VSI -8%) management is taking "a more cautious view on the year" after saying...

Vitamin Shoppe's (VSI -8%) management is taking "a more cautious view on the year" after saying variability in YTD sales performance and weaker than expected sales in April should translate to comps growth in the "low-to-mid single digits." That's a downward revision from previous guidance. Comps growth was 4.5% in Q1, down markedly from 9.6% in Q1 2012 and off by 0.7% sequentially. VSI does note on the call however, that 2012 Q1 comps benefited from "higher whey protein inflation." (PR, transcript)
Comments (1)
  • rambler1
    , contributor
    Comments (398) | Send Message
     
    I wonder how much the absence of Jack3D without DMAA in it was influencing sales. I didn't see or hear any reference to it.
    8 May 2013, 08:40 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|